Literature DB >> 23868270

Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials.

Georgios D Kitsios1, David E Thaler, David M Kent.   

Abstract

Entities:  

Keywords:  foramen ovale, patent; meta-analysis; patent foramen ovale closure; secondary prevention; stroke

Mesh：

Year:  2013        PMID： 23868270      PMCID： PMC3821529          DOI： 10.1161/STROKEAHA.113.001773

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  8 in total

1.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 2.  Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence.

Authors:  Georgios D Kitsios; Issa J Dahabreh; Abd Moain Abu Dabrh; David E Thaler; David M Kent
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

3.  Cumulative meta-analysis of therapeutic trials for myocardial infarction.

Authors:  J Lau; E M Antman; J Jimenez-Silva; B Kupelnick; F Mosteller; T C Chalmers
Journal:  N Engl J Med       Date:  1992-07-23       Impact factor: 91.245

4.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

5.  Long-term mortality after stroke among adults aged 18 to 50 years.

Authors:  Loes C A Rutten-Jacobs; Renate M Arntz; Noortje A M Maaijwee; Henny C Schoonderwaldt; Lucille D Dorresteijn; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  JAMA       Date:  2013-03-20       Impact factor: 56.272

6.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Authors:  John D Carroll; Jeffrey L Saver; David E Thaler; Richard W Smalling; Scott Berry; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

7.  Percutaneous closure of patent foramen ovale in cryptogenic embolism.

Authors:  Bernhard Meier; Bindu Kalesan; Heinrich P Mattle; Ahmed A Khattab; David Hildick-Smith; Dariusz Dudek; Grethe Andersen; Reda Ibrahim; Gerhard Schuler; Antony S Walton; Andreas Wahl; Stephan Windecker; Peter Jüni
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

8.  Still no closure on the question of PFO closure.

Authors:  Steven R Messé; David M Kent
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245
  8 in total
  15 in total

1.  Controversies in cardioembolic stroke.

Authors:  Benjamin S Wessler; David M Kent
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-01

Review 2.  Prevention of recurrent stroke in patients with patent foramen ovale.

Authors:  Benjamin S Wessler; David M Kent
Journal:  Neurol Clin       Date:  2015-02-28       Impact factor: 3.806

3.  PFO and ASD Closure in Adulthood: Where Do We Stand?

Authors:  Asad A Rizvi; Ronan Margey
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04

Review 4.  Transcatheter closure of PFO as secondary prevention of cryptogenic stroke.

Authors:  R De Vecchis; C Baldi; S Cantatrione
Journal:  Herz       Date:  2016-06-02       Impact factor: 1.443

5.  Response to letter regarding article, "Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials".

Authors:  David M Kent; Georgios D Kitsios; David E Thaler
Journal:  Stroke       Date:  2013-11-05       Impact factor: 7.914

Review 6.  Leptin receptor action and mechanisms of leptin resistance.

Authors:  H Münzberg; M Björnholm; S H Bates; M G Myers
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

7.  Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke.

Authors:  David E Thaler; Robin Ruthazer; Christian Weimar; Joaquín Serena; Heinrich P Mattle; Krassen Nedeltchev; Marie-Luise Mono; Emanuele Di Angelantonio; Mitchell S V Elkind; Marco R Di Tullio; Shunichi Homma; Patrik Michel; Bernhard Meier; Anthony J Furlan; Jennifer S Lutz; David M Kent
Journal:  Neurology       Date:  2014-10-22       Impact factor: 9.910

Review 8.  Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale.

Authors:  Frederick A Spencer; Luciane C Lopes; Sean A Kennedy; Gordon Guyatt
Journal:  BMJ Open       Date:  2014-03-07       Impact factor: 2.692

Review 9.  Strokes in young adults: epidemiology and prevention.

Authors:  Dževdet Smajlović
Journal:  Vasc Health Risk Manag       Date:  2015-02-24

Review 10.  Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.

Authors:  Jie Li; Junfeng Liu; Ming Liu; Shihong Zhang; Zilong Hao; Jing Zhang; Canfei Zhang
Journal:  Cochrane Database Syst Rev       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.